Comparing TNF Pharmaceuticals (NASDAQ:TNFA) and Ricoh (OTCMKTS:RICOY)

TNF Pharmaceuticals (NASDAQ:TNFAGet Free Report) and Ricoh (OTCMKTS:RICOYGet Free Report) are both technology companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.

Insider and Institutional Ownership

9.6% of TNF Pharmaceuticals shares are held by institutional investors. 0.4% of TNF Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility & Risk

TNF Pharmaceuticals has a beta of 2.04, indicating that its stock price is 104% more volatile than the S&P 500. Comparatively, Ricoh has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations for TNF Pharmaceuticals and Ricoh, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TNF Pharmaceuticals 1 0 0 0 1.00
Ricoh 0 0 0 0 0.00

Profitability

This table compares TNF Pharmaceuticals and Ricoh’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TNF Pharmaceuticals N/A -69.21% -33.98%
Ricoh 3.10% 6.98% 3.24%

Valuation & Earnings

This table compares TNF Pharmaceuticals and Ricoh”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
TNF Pharmaceuticals N/A N/A -$23.36 million ($231.00) -0.01
Ricoh $17.33 billion 0.31 $367.42 million $0.94 10.16

Ricoh has higher revenue and earnings than TNF Pharmaceuticals. TNF Pharmaceuticals is trading at a lower price-to-earnings ratio than Ricoh, indicating that it is currently the more affordable of the two stocks.

Summary

Ricoh beats TNF Pharmaceuticals on 7 of the 11 factors compared between the two stocks.

About TNF Pharmaceuticals

(Get Free Report)

TNF Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company. It focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases. The company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

About Ricoh

(Get Free Report)

Ricoh Company, Ltd. provides office, commercial printing, and related solutions worldwide. It operates through Digital services, Digital Products, Graphic Communications, Industrial Solutions, and Other segments. The company sells multifunctional printers (MFPs), laser printers, digital duplicators, wide format printers, facsimile machines, scanners, personal computers, servers, network equipment, related parts and supplies, services, and support and service and solutions related to documents. It also offers production and OEM services for MFPs, laser printers, digital duplicators, wide format printers, facsimile machine, scanners, network equipment, and related parts and supplies. In addition, the company produces and sells cut sheet printers, continuous feed printers, inkjet heads, imaging systems, industrial printers, related parts and supplies, services, and support and software. Further, it produces and sells thermal paper and media products, industrial optical components/modules, and electronic components and precision mechanical components, as well as offers digital cameras, 360°cameras, and environment and healthcare products. The company was formerly known as Riken Optical Co., Ltd. and changed its name to Ricoh Company, Ltd. in 1963. Ricoh Company, Ltd. was incorporated in 1936 and is headquartered in Tokyo, Japan.

Receive News & Ratings for TNF Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TNF Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.